Crystal structure of human dehydroepiandrosterone sulphotransferase in complex with substrate.

Dehydroepiandrosterone sulphotransferase (DHEA-ST) is an enzyme that converts dehydroepiandrosterone (DHEA), and some other steroids, into their sulphonated forms. The enzyme catalyses the sulphonation of DHEA on the 3alpha-oxygen, with 3'-phosphoadenosine-5'-phosphosulphate contributing the sulphate. The structure of human DHEA-ST in complex with its preferred substrate DHEA has been solved here to 1.99 A using molecular replacement with oestradiol sulphotransferase (37% sequence identity) as a model. Two alternative substrate-binding orientations have been identified. The primary, catalytic, orientation has the DHEA 3alpha-oxygen and the highly conserved catalytic histidine in nearly identical positions as are seen for the related oestradiol sulphotransferase. The substrate, however, shows rotations of up to 30 degrees, and there is a corresponding rearrangement of the protein loops contributing to the active site. This may also reflect the low identity between the two enzymes. The second orientation penetrates further into the active site and can form a potential hydrogen bond with the desulphonated cofactor 3',5'-phosphoadenosine (PAP). This second site contains more van der Waal interactions with hydrophobic residues than the catalytic site and may also reflect the substrate-inhibition site. The PAP position was obtained from the previously solved structure of DHEA-ST co-crystallized with PAP. This latter structure, due to the arrangement of loops within the active site and monomer interactions, cannot bind substrate. The results presented here describe details of substrate binding to DHEA-ST and the potential relationship to substrate inhibition.

[1]  V. Luu‐The,et al.  Crystallization and preliminary crystallographic results of apo and complex forms of human dehydroepiandrosterone sulfotransferase. , 2001, Acta crystallographica. Section D, Biological crystallography.

[2]  L. Pedersen,et al.  Structure and function of sulfotransferases. , 2001, Archives of biochemistry and biophysics.

[3]  M. Zhou,et al.  Human dehydroepiandrosterone sulfotransferase: purification and characterization of a recombinant protein , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  K. Tomer,et al.  The dimerization motif of cytosolic sulfotransferases , 2001, FEBS letters.

[5]  L. Pedersen,et al.  Crystal structure of SULT2A3, human hydroxysteroid sulfotransferase , 2000, FEBS letters.

[6]  E. Elias,et al.  Reduced hepatic content of dehydroepiandrosterone sulphotransferase in chronic liver diseases. , 2000, Liver.

[7]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[8]  L. Pedersen,et al.  Crystal structure of estrogen sulphotransferase , 1997, Nature Structural Biology.

[9]  C. Falany Enzymology of human cytosolic sulfotransferases , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Khaw Kt Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. , 1996 .

[11]  C. Falany,et al.  Effect of TGF‐β on Dehydroepiandrosterone Sulfotransferase in Cultured Human Fetal Adrenal Cells , 1995, Annals of the New York Academy of Sciences.

[12]  K. A. Comer,et al.  Human Dehydroepiandrosterone Sulfotransferase , 1995 .

[13]  F. Labrie,et al.  Structural characterization and expression of the human dehydroepiandrosterone sulfotransferase gene. , 1995, DNA and cell biology.

[14]  J. Simard,et al.  No evidence of mutations in the genes for type I and type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) in nonclassical 3 beta HSD deficiency. , 1994, The Journal of clinical endocrinology and metabolism.

[15]  B. Martin,et al.  Isolation of two distinct 3-hydroxysteroid sulfotransferases from the guinea pig adrenal. Evidence for 3 alpha-hydroxy versus 3 beta-hydroxy stereospecificity. , 1993, Journal of Biological Chemistry.

[16]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[17]  W. Driscoll,et al.  Molecular cloning and expression of a full-length complementary DNA encoding the guinea pig adrenocortical estrogen sulfotransferase. , 1992, Molecular endocrinology.

[18]  R. Weinshilboum,et al.  Human liver dehydroepiandrosterone sulfotransferase: molecular cloning and expression of cDNA. , 1992, Molecular pharmacology.

[19]  M. Coughtrie,et al.  Inhibition of human liver steroid sulfotransferase activities by drugs: a novel mechanism of drug toxicity? , 1992, European journal of pharmacology.

[20]  B. Chatterjee,et al.  Estrogen sulfotransferase of the rat liver: complementary DNA cloning and age- and sex-specific regulation of messenger RNA. , 1992, Molecular endocrinology.

[21]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[22]  R. Kato,et al.  cDNA cloning of the hydroxysteroid sulfotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP-2 in rat livers. , 1990, Biochemical and biophysical research communications.

[23]  John B. Adams Control of secretion and the function of C19-Δ5-steroids of the human adrenal gland , 1985, Molecular and Cellular Endocrinology.

[24]  C. Falany,et al.  Effects of ACTH and cytokines on dehydroepiandrosterone sulfotransferase messenger RNA in human adrenal cells. , 1998, Endocrine research.

[25]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[26]  F. Bernier,et al.  Steroid sulfotransferases. , 1996, The Journal of endocrinology.

[27]  C. Longcope Dehydroepiandrosterone metabolism. , 1996, The Journal of endocrinology.

[28]  K. Khaw Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. , 1996, The Journal of endocrinology.

[29]  K. A. Comer,et al.  Human dehydroepiandrosterone sulfotransferase. Purification, molecular cloning, and characterization. , 1995, Annals of the New York Academy of Sciences.

[30]  K. A. Comer,et al.  Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. , 1993, Molecular pharmacology.

[31]  F. Labrie,et al.  Complete androgen blockade for the treatment of prostate cancer. , 1985, Important advances in oncology.

[32]  J. Adams Control of secretion and the function of C19-delta 5-steroids of the human adrenal gland. , 1985, Molecular and cellular endocrinology.

[33]  K. Rajagopalan,et al.  from Human Liver , 1976 .